D
Diederick E. Grobbee
Researcher at Utrecht University
Publications - 1108
Citations - 136069
Diederick E. Grobbee is an academic researcher from Utrecht University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 155, co-authored 1051 publications receiving 122748 citations. Previous affiliations of Diederick E. Grobbee include National Heart Foundation of Australia & Radboud University Nijmegen Medical Centre.
Papers
More filters
Journal ArticleDOI
The effect of non-organophosphate household pesticides exposure during pregnancy on infants birth sizes and growth rate: a cohort study
Frida Soesanti,Frida Soesanti,Nikmah Salamia Idris,Nikmah Salamia Idris,Kerstin Klipstein-Grobusch,Kerstin Klipstein-Grobusch,Aryono Hendarto,Diederick E. Grobbee,Cuno S.P.M. Uiterwaal +8 more
TL;DR: It is suggested that antenatal exposure to household non-organophosphate pesticides is associated with smaller head circumference at birth, and no modification of effects by breastfeeding was found.
Journal ArticleDOI
Accreditation of clinical centres providing primary prevention, secondary prevention and rehabilitation, and sports cardiology: A step towards optimizing quality:
TL;DR: It is necessary to select patients suitable for palliative care on the basis of prior history and once they provide informed consent for surgery to select those suitable for surgery with a history of adverse events.
Journal ArticleDOI
The association between HIV infection and pulmonary function in a rural African population.
Meri R.J. Varkila,Alinda G. Vos,Alinda G. Vos,Roos E. Barth,Hugo A. Tempelman,Walter Devillé,Roel A. Coutinho,Diederick E. Grobbee,Kerstin Klipstein-Grobusch,Kerstin Klipstein-Grobusch +9 more
TL;DR: Pulmonary function is affected by HIV infection which most likely results from co-infection with TB or other pneumonia, especially as the incidence of TB is high in HIV infection.
Journal ArticleDOI
Cardiovascular disease risk in an urban African population : a cross-sectional analysis on the role of HIV and antiretroviral treatment
Alinda G. Vos,Alinda G. Vos,Klariska Hoeve,Roos E. Barth,Joyce Peper,Michelle Moorhouse,Nigel J. Crowther,Willem D F Venter,Diederick E. Grobbee,Michiel L. Bots,Kerstin Klipstein-Grobusch,Kerstin Klipstein-Grobusch +11 more
TL;DR: Neither HIV nor ART was associated with CIMT or carotid distensibility in this urban African population and further adjustment for CVD and HIV-related factors did not alter the findings.
Journal ArticleDOI
Association of Factor V Leiden with Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data
Bakhtawar K. Mahmoodi,Vinicius Tragante,Marcus E. Kleber,Michael V. Holmes,Michael V. Holmes,Amand F. Schmidt,Amand F. Schmidt,Raymond O McCubrey,Laurence J. Howe,Kenan Direk,Hooman Allayee,Ekaterina V Baranova,Peter S. Braund,Peter S. Braund,Graciela E. Delgado,Niclas Eriksson,Crystel M. Gijsberts,Yan Gong,Jaana Hartiala,Mahyar Heydarpour,Mahyar Heydarpour,Gerard Pasterkamp,Salma Kotti,Pekka Kuukasjärvi,Petra A. Lenzini,Daniel Levin,Leo-Pekka Lyytikäinen,Jochen D. Muehlschlegel,Jochen D. Muehlschlegel,Christopher P. Nelson,Christopher P. Nelson,Kjell Nikus,Anna P. Pilbrow,W.H. Wilson Tang,W.H. Wilson Tang,Sander W. van der Laan,Jessica van Setten,Ragnar O. Vilmundarson,John E. Deanfield,Panos Deloukas,Frank Dudbridge,Stefan James,Ify R. Mordi,Andrej Teren,Thomas O. Bergmeijer,Simon C. Body,Michiel L. Bots,Michiel L. Bots,Ralph Burkhardt,Rhonda M. Cooper-DeHoff,Sharon Cresci,Nicolas Danchin,Robert N. Doughty,Diederick E. Grobbee,Emil Hagström,Stanley L. Hazen,Stanley L. Hazen,Claes Held,Imo E. Hoefer,G. Kees Hovingh,Julie A. Johnson,Marcin P. Kaczor,Mika Kähönen,Olaf H. Klungel,Jari Laurikka,Terho Lehtimäki,Anke H. Maitland-van der Zee,Anke H. Maitland-van der Zee,Ruth McPherson,Colin N. A. Palmer,Adriaan O. Kraaijeveld,Carl J. Pepine,Marek Sanak,Naveed Sattar,Markus Scholz,Tabassome Simon,Tabassome Simon,John A. Spertus,Alexandre F.R. Stewart,Wojciech Szczeklik,Joachim Thiery,Frank L.J. Visseren,Johannes Waltenberger,A. Mark Richards,A. Mark Richards,Chim C. Lang,Vicky A. Cameron,Axel Åkerblom,Guillaume Paré,Guillaume Paré,Winfried März,Winfried März,Winfried März,Nilesh J. Samani,Nilesh J. Samani,Aroon D. Hingorani,Jurriën M. ten Berg,Lars Wallentin,Folkert W. Asselbergs,Folkert W. Asselbergs,Riyaz S. Patel,Riyaz S. Patel +101 more
TL;DR: Factor V Leiden was not associated with increased risk of subsequent atherothrombotic events and mortality in high-risk participants with established and treated CHD, and risk estimates for the secondary outcomes including stroke, coronary revascularization, cardiovascular mortality, and all-cause mortality were close to identity.